Related Experiment Video
Updated: Jun 2, 2025

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis
Published on: September 26, 2012
Impaired Presynaptic Function Contributes Significantly to the Pathology of Glycine Receptor Autoantibodies
Anna-Lena Wiessler1, Fang Zheng2, Christian Werner3
1Institute for Clinical Neurobiology, University Hospital, Julius-Maximilians-University of Würzburg, Germany.
Autoantibodies against glycine receptors (GlyRs) can affect presynaptic function, impacting neurological conditions like stiff person syndrome (SPS) and progressive encephalomyelitis with rigidity and myoclonus (PERM). This study reveals GlyRα2 as a key presynaptic target, explaining diverse patient symptoms.
Area of Science:
- Neuroimmunology
- Synaptic Plasticity
- Autoimmune Neurological Disorders
Background:
- Autoantibodies (aAbs) targeting glycine receptors (GlyRs) are linked to stiff person syndrome (SPS) and progressive encephalomyelitis with rigidity and myoclonus (PERM).
- Previous research focused on aAbs affecting postsynaptic GlyRs, but presynaptic effects remained unexplored.
- GlyR aAbs can bind to various GlyR α-subunits and occasionally the β-subunit.
Purpose of the Study:
- To investigate whether autoantibodies against GlyRs also impact the expression and function of presynaptic homomeric GlyRs.
- To determine the role of presynaptic GlyR autoantibodies in the pathophysiology of autoimmune neurological diseases.
Main Methods:
- Established interneuron cultures from mouse embryonic spinal cord neurons.
- Employed protein biochemistry and super-resolution microscopy to analyze aAb binding to presynaptic GlyRs.
- Utilized brainstem slice recordings to assess functional alterations in synaptic transmission.
Main Results:
- Exposure to GlyR aAbs did not alter the expression of proteins forming a functional glycinergic synapse, except for increased glycine transporter 2 (GlyT2) expression.
- Super-resolution microscopy showed patient-derived aAbs binding to both postsynaptic and presynaptic sites, with GlyRα2 identified as a predominant presynaptic GlyR subunit.
- Functional recordings demonstrated a significant reduction in inhibitory postsynaptic potential frequency due to presynaptic aAb binding.
Conclusions:
- This study provides the first evidence implicating presynaptic GlyR defects in the pathophysiology of autoimmune diseases like SPS and PERM.
- The diverse clinical manifestations and therapeutic responses in patients with GlyR autoimmunity are attributed to individually tuned binding preferences for presynaptic and postsynaptic targets.
- GlyRα2 is identified as a significant presynaptic target for autoantibodies in these neurological conditions.
More Related Videos
08:33Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
Published on: June 25, 2019
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
Related Concept Videos
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Proteoglycans
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Lysosomal Hydrolases